Boundless Bio, Inc. (BOLD)
2025-06-30 | ||||
---|---|---|---|---|
Research and development | 12,218 | |||
General and administrative | 4,843 | |||
Total operating expenses | 17,061 | |||
Loss from operations | -17,061 | |||
Other income/ (expense), net | - | |||
Interest income | 1,386 | |||
Total other income, net | 1,386 | |||
Net loss | -15,675 | |||
Earnings per share, diluted, total | -0.7 | |||
Net loss per common share - basic | -0.7 | |||
Weighted average number of shares outstanding, basic, total | 22,356,000 | |||
Weighted average number of shares outstanding, diluted, total | 22,356,000 |